ABOUT OCT CLINICAL
OCT is one of the leading contract research organizations in Europe. Since 2005, the OCT team has conducted over 300 clinical trials in 29 therapeutic areas. The team of 200+ professionals provides a full range of high-quality CRO services for Phase I-IV and BE studies, with therapeutic expertise in oncology, cardiovascular, infectious diseases, rheumatology, GI, and other areas.
With strong local expertise and focus on quality, OCT Clinical ensures seamless clinical trial conduct and drug registration, on time and within budget.
Only target clinical trial participants
Since its foundation, OCT has successfully enrolled over 50,000 patients while preserving budgets and timelines.
With 20+ years of accumulated experience, our team has established efficient cooperation with 1600 research sites. Thorough feasibility analysis, coupled with well-coordinated communication with sites, allows us to recruit with minimal screen failure rates.
Full-service clinical study engagements
- Clinical Study Design Preparation
- Medical Writing
- Consulting and Regulatory Support
- Project Management and Monitoring
- Drug Safety and Pharmacovigilance
- Data Management
- Biostatistics
- Clinical Supply Services and Logistics
- Marketing Authorization
- GMP Inspection Support
Rescue studies as a special expertise
Another specialty area for the OCT team is rescue studies. When clinical trials hit roadblocks, the team is ready to step in. When a takeover of an active trial is needed, the OCT Clinical experts create a study rescue plan focused on resolving current bottlenecks and study challenges and an expedited study schedule to get it back on track.
FEATURED VIDEOS
Every pharmaceutical company conducts a clinical trial before introducing a new medicine to the market. Learn how to meet clinical trial deadlines and stay within budget using an effective data management platform.
This webinar explains how to create and manage successful budgets, uncover and avoid hidden costs, and minimize the pandemic’s financial impact.
Discover how to assemble analysis data, and learn more about the basics of ADaM standards and details of the standard structures for analysis datasets.
Discover how the new framework will improve the way of designing and planning clinical trials and performing primary analyses and sensitivity analyses.
Are your pharma clinical trials running over budget? What expenses can you cut without compromising quality? This free webinar will cover reasons trial spending might exceed proposed costs and how to navigate shifting study needs while maintaining a budget.
CONTACT INFORMATION
OCT Clinical
Fischertwiete 2 (Chilehaus A)
Hamburg, 191014
GERMANY
Phone: +49 40 32005005
Contact: germany@oct-clinicaltrials.com; and public relations contact: pr@oct-clinicaltrials.com
FEATURED ARTICLES
-
![GettyImages-1296415689 trial diversity]( "Racial Diversity In Trials: Clinical Findings, Challenges, And The Role Of CROs")
Race and ethnic inclusion matter. When creating a clear picture of the safety and efficacy of a drug, uncover diversity's critical role in studies for providing clinically meaningful insights.
-
![GettyImages-1169924346 patient data collection]( "Completing Recruitment In 4 Countries In A Study For ED")
Uncover how a leading Eastern European CRO completed patient recruitment ahead of schedule in an erectile dysfunction study involving the evaluation of an innovative MED3000 topical gel.
-
![GettyImages-1372189785 waiting room]( "Study Completes Recruitment, Overcomes Pandemic Hurdles")
Amid challenges during the COVID-19 pandemic, discover how recruitment was completed in three countries for a Sweden-based pharmaceutical company's phase 2b study.
-
![GettyImages-1184550673 doctor patient]( "Transform Your Clinical Trials In Eastern Europe")
Gain insight into why research sites in Central and Eastern European countries are becoming popular destinations for clinical trials with the latest industry Pages™ Report.
-
![GettyImages-862229772 communication]( "What Do Biostatisticians Think Of The ICH E9(R1) Addendum?")
Gain insights from Kristina Bondareva, Head of Biostatistics at OCT Clinical, on the significance of the Addendum and the importance of adopting the estimand framework in clinical trials.
-
![GettyImages-1325005895 covid]( "3 Years Later: How Hard It Was To Develop And Research A COVID-19 Vaccine")
Unearth some of the challenges and prospects faced by clinical trial teams working on vaccine development against COVID-19.
-
![GettyImages-1196203326 estimands]( "Time-To-Event Analysis In Oncology Through The Prism Of Estimands")
Considering an ICH E9R(1) Addendum on Estimands and Sensitivity Analysis, several sensitivity analyses are now regarded as supplementary analyses. Learn about these changes and their effects oncology trials.
-
![GettyImages-1226888991 oncology data]( "Data Management Solution For A Clinical-Stage Cancer Immunotherapy Study")
Check out the results from a clinical first-in-human study evaluating the safety and tolerability of an investigational cancer immunotherapy in patients with advanced melanoma.
-
![Woman-Cancer-and-Doctor-GettyImages-1141776223]( "Maximizing Efficiency In Data Management Services In A Breast Cancer Study")
Learn how database validation, database lock, and the development of the electronic CRF were used in a HER2-positive operable breast cancer study.
-
![scientist research data iStock-1140779713]( "Preparing Data Packages For Regulatory Submission")
Gain insight into how a dermatology-specialized European CRO joined forces to carry out interim statistical analysis in its study on seven subjects and prepared necessary data packages for regulatory submission.
